Exvastat wins a 3.6 million euro grant for COVID-19 trial
Congratulations to Cambridge Innovation Capital portfolio company Exvastat that has been awarded a grant from the prestigious Innovative Medicines Initiative. ...Read more >
News
Maintaining an agile and collaborative approach during the COVID-19 Pandemic
Simbec-Orion COVID-19 Update 1 April 2020
Lending a Hand to Support Rare Disease Day
As a CRO focusing on rare disease, we are delighted to support EURODIS’s 12th international Rare Disease Day. Taking inspiration from ...Read more >
Read The Latest Article, Engaging With Patients And Experts To Develop New Drugs
Dr Fabrice Chartier explains the complex nature of developing treatments for rare diseases. Read the article on page 17.
Simbec-Orion Receives The “CRO Of The Year” Award At 2019 European Lifestars AwardsTM
Celebrating success across life sciences London, UK, November 25th 2019. Simbec-Orion is pleased to announce that it has been recognised ...Read more >